Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

FRA/BSX stock hub

FRA/BSX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/BSXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

68.1B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/BSX

In the news

Latest news · FRA/BSX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E15.5

P25 12.3P50 15.7P75 20.2

Trailing P/E22

P25 16.4P50 20.9P75 30.4

ROE14.7

P25 -6.7P50 8.5P75 17.2

ROIC11.1

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/BSX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

231

Groups with data

Currency

USD

Showing 231 of 231 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	59,000
Employees Change	5,000%
Employees Change Percent	10.42
Enterprise value	EUR 76.4B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical Devices
Isin	US1011371077
Last refreshed	2026-05-10
Market cap	EUR 68.1B
Price	EUR 49.22
Price currency	EUR
Rev Per Employee	303,025.8x
Sector	Healthcare
Sic	3845
Symbol	fra/BSX
Website	https://www.bostonscientific.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.54%
EV Earnings	24.72x
EV/EBIT	21.91x
EV/EBITDA	16.36x
EV/FCF	25.36x
EV/Sales	4.36x
FCF yield	4.43%
Forward P/E	15.5x
P/B ratio	3.01x
P/E ratio	22.03x
P/S ratio	3.81x
PE Ratio10 Y	88.45x
PE Ratio3 Y	60.97x
PE Ratio5 Y	69.72x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	19.92%
EBITDA Margin	26.68%
FCF margin	16.86%
Gross margin	68.94%
Gross Profit	EUR 12.3B
Gross Profit Growth	18.28%
Gross Profit Growth Q	12.67%
Gross Profit Growth3 Y	16.63%
Gross Profit Growth5 Y	15.5%
Net Income	EUR 3.1B
Net Income Growth	75.44%
Net Income Growth Q	98.96%
Net Income Growth Quarters	6%
Net Income Growth Years	3%
Net Income Growth3 Y	61.52%
Net Income Growth5 Y	77.73%
Pretax Margin	18.16%
Profit Margin	17.29%
Profit Per Employee	EUR 52,406
Profitable Years	5
ROA	6.07
Roa5y	4.61
ROCE	10.32
ROE	14.66
Roe5y	8.1
ROIC	11.13
Roic5y	7.52

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	9.88%
Cagr15y	16.32%
Cagr1y	-46.29%
Cagr20y	5.43%
Cagr3y	1.66%
Cagr5y	6.52%
EPS Growth	74.39
EPS Growth Q	100
EPS Growth Quarters	6
EPS Growth Years	3
EPS Growth3 Y	59.39
EPS Growth5 Y	76.04
FCF Growth	15.3%
FCF Growth Q	-51.7%
FCF Growth3 Y	42.69%
FCF Growth5 Y	18.01%
OCF Growth	13.88%
OCF Growth Q	-35.68%
OCF Growth10 Y	16.87%
OCF Growth3 Y	34.76%
OCF Growth5 Y	18.36%
Revenue Growth	17.43x
Revenue Growth Q	11.58x
Revenue Growth Quarters	21x
Revenue Growth Years	5x
Revenue Growth3 Y	16.48x
Revenue Growth5 Y	15.29x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.49
Assets	EUR 38.5B
Cash	EUR 1.3B
Current Assets	EUR 7.4B
Current Liabilities	EUR 3.9B
Debt	EUR 9.6B
Debt EBITDA	EUR 2.01
Debt Equity	EUR 0.42
Debt FCF	EUR 3.17
Equity	EUR 22.6B
Interest Coverage	11.5
Liabilities	EUR 15.8B
Long Term Assets	EUR 31.1B
Long Term Liabilities	EUR 11.9B
Net Cash	EUR -8.3B
Net Cash By Market Cap	EUR -12.2
Net Debt EBITDA	EUR 1.74
Net Debt Equity	EUR 0.37
Net Debt FCF	EUR 2.76
Tangible Book Value	EUR 232.4M
Tangible Book Value Per Share	EUR 0.16

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.9
Inventory Turnover	2.14
Net Working Capital	EUR 2.3B
Quick ratio	0.98
Working Capital	EUR 3.6B
Working Capital Turnover	EUR 5.6

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.42%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	156.6%
1Y total return	-46.27%
200-day SMA	76.21
3Y total return	5.05%
50-day SMA	56.47
50-day SMA vs 200-day SMA	50under200
5Y total return	37.13%
All Time High	105
All Time High Change	-53.13%
All Time High Date	2025-02-11
All Time Low	3.83
All Time Low Change	1,185.99%
All Time Low Date	2011-10-24
ATR	1.45
Ch YTD	-39.24
High	49.33
High52	95.8
High52 Date	2025-05-20
High52ch	-48.63%
Low	48.09
Low52	47.79
Low52 Date	2026-05-07
Low52ch	4.82%
Ma50ch	-12.85%
Price vs 200-day SMA	-35.42%
RSI	35.29
RSI Monthly	30.06
RSI Weekly	24.53
Sharpe ratio	-1.9x
Sortino ratio	-2.17
Total Return	-0.42%
Tr YTD	-39.24
Tr15y	865.57%
Tr1m	-7.53%
Tr1w	0.48%
Tr3m	-25.43%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 3.6B
Operating Income Growth	26.49
Operating Income Growth Q	14.41
Operating Income Growth3 Y	24.38
Operating Income Growth5 Y	26.87
Operating margin	19.92

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,482,065,479%
Net Borrowing	-845,418,114
Shares Insiders	0.19%
Shares Institutions	91.73%
Shares Qo Q	-0.05%
Shares Yo Y	0.42%
Short Ratio	1.58

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 2.7B
Average Volume	317.1x
Bv Per Share	15.09
CAPEX	EUR -751.1M
Ch10y	156.6
Ch15y	865.6
Ch1m	-7.53
Ch1w	0.48
Ch1y	-46.27
Ch20y	188.1
Ch3m	-25.43
Ch3y	5.05
Ch5y	37.13
Ch6m	-42.1
Change	1.1%
Change From Open	2.34
Close	48.68
Days Gap	-1.21
Depreciation Amortization	1,182,059,028
Dollar Volume	738.2
Earnings Date	2026-04-22
EBIT	EUR 3.6B
EBITDA	EUR 4.8B
EPS	EUR 2.07
F Score	7
FCF	EUR 3B
FCF EV Yield	3.94x
Financing CF	-770,162,400
Fiscal Year End	December
Founded	1,979
Goodwill	15,717,823,632
Graham Number	28.67965
Graham Upside	-41.73
Income Tax	EUR 159.6M
Investing CF	-2,368,596,300
Is Primary Listing	0
Last Earnings Date	2026-04-22
Last Report Date	2026-03-31
Last Split Date	2003-11-06
Last Split Type	Forward
Lynch Fair Value	EUR 55.86
Lynch Upside	13.5
Ma150	72.15
Ma150ch	-31.79%
Ma20	51.96
Ma20ch	-5.28%
Net CF	627,925,200
Next Earnings Date	2026-07-29
Open	48.09
P FCF Ratio	22.6
P OCF Ratio	18.09
Position In Range	90.73
Ppne	3,909,104,820
Price Date	2026-05-08
Price EBITDA	EUR 14.28
Ptbv Ratio	293
Relative Volume	0.05x
Revenue	17,878,522,200x
SBC By Revenue	1.49x
Share Based Comp	267,128,400
Tax By Revenue	0.89x
Tax Rate	4.92%
Tr20y	188.14%
Tr6m	-42.1%
Volume	15
Z Score	5.77

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/BSX pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/BSX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/BSX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+91.7%

Share of float held by funds and institutions

Insider ownership

+0.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/BSX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

35.3

Neutral momentum band

Price vs 200-day MA

-35.4%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-1.90

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/BSX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/BSX stock rating?

fra/BSX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/BSX analysis?

The full report lives at /stocks/fra/BSX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/BSX?

The latest report frames fra/BSX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/BSX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.